Stephen F. Mahoney's Net Worth

$2.48 Million

Estimate Recalculated Nov 11, 2024 01:19PM EST

Who is Stephen F. Mahoney

Stephen F. Mahoney has an estimated net worth of $2.48 Million. This is based on reported shares across multiple companies, which include Kiniksa Pharmaceuticals, Ltd., Magenta Therapeutics, Inc., and Viridian Therapeutics, Inc.\DE.

SEC CIK

Stephen F. Mahoney's CIK is 0001741389

Past Insider Trading and Trends

2018 was Stephen F. Mahoney's most active year for acquiring shares with 4 total transactions. Stephen F. Mahoney's most active month to acquire stocks was the month of April. 2018 was Stephen F. Mahoney's most active year for disposing of shares, totalling 2 transactions. Stephen F. Mahoney's most active month to dispose stocks was the month of April. 2018 saw Stephen F. Mahoney paying a total of $99,995.17 for 169,834 shares, this is the most they've acquired in one year. In 2021 Stephen F. Mahoney cashed out on 5,736 shares for a total of $38,603.28, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kiniksa Pharmaceuticals, Ltd.

President & COO
Updated Sep 19, 2019
Form 4
82.00K
Sep 19, 2019
82.00K
Grant
Sep 17
Form 4
83.00K
Mar 06, 2019
83.00K
Grant
Mar 04
Form 4
50.00K
Sep 24, 2018
50.00K
Grant
Sep 20
Form 4
0.88%
6.39K
$15.64
$100.00K
May 29, 2018
772.21K
Purchase
Feb 09 - May 29
Form 3
May 23, 2018
109.80K
Showing 5 results

Magenta Therapeutics, Inc.

See Remarks
Updated Dec 02, 2022
Form 4
21.03%
3.00K
$0.94
$2.82K
Dec 02, 2022
17.26K
Grant
Nov 30
Form 4
130.00K
Aug 01, 2022
130.00K
Grant
Aug 01
Form 4
62.50K
May 19, 2022
62.50K
Grant
May 17
Form 4
130.00K
Feb 17, 2022
130.00K
Grant
Feb 15
Form 4
-28.68%
-5.74K
$6.73
-$38.60K
Sep 20, 2021
14.26K
Sale
Sep 16
Form 4
20.00K
Sep 16, 2021
20.00K
Grant
Sep 14
Form 4
435.00K
Nov 04, 2020
435.00K
Grant
Nov 02
Form 3
Nov 04, 2020
Showing 8 results

Viridian Therapeutics, Inc.\DE

President and CEO
Updated Nov 01, 2023
Form 4
1.26M
Nov 01, 2023
1.26M
Grant
Oct 30
Form 3
Nov 01, 2023
Showing 2 results